ABBOTT LABORATORIES - Brand Breakdown

abt
Author

Kevin Bird

Published

March 8, 2025

What Brands Does Abbott Own?

1. Medical Devices (Largest revenue segment, strong growth)

  • Diabetes Care – FreeStyle Libre™, Lingo™ (dominant in CGM market)
  • Structural Heart – MitraClip™, Amplatzer™, TAVR devices
  • Cardiac Rhythm Management – Pacemakers, defibrillators
  • Vascular – Stents, closure devices
  • Heart Failure – LVADs, remote monitoring
  • Electrophysiology – Catheters, mapping systems
  • Neuromodulation – Spinal cord, deep brain stimulators

2. Diagnostic Products (Pandemic-driven surge, still a key but declining segment)

  • Rapid Diagnostics – BinaxNOW™, Panbio™ (COVID testing impact)
  • Core Lab & Transfusion – Alinity™, ARCHITECT™
  • Molecular Diagnostics – Alinity m™, PCR-based tests
  • Point-of-Care – i-STAT™, ID NOW™
  • Informatics & Automation – AlinIQ™, lab automation

3. Nutritional Products (Steady demand, strong brand presence)

  • Infant Formula – Similac™, EleCare™ (hit by recall but recovering)
  • Adult Nutrition – Ensure™, Glucerna™, PediaSure™
  • Enteral Feeding – Jevity™, Nepro™

4. Established Pharmaceuticals (Branded generics, sold mostly outside U.S.)

  • Gastroenterology – Creon™, Duphalac™
  • Cardiovascular & Metabolic – Lipanthyl™, Synthroid™
  • Pain & CNS – Brufen™, Serc™
  • Women’s Health – Duphaston™, Femoston™
  • Respiratory & Vaccines – Klaricid™, Influvac™
  • Biosimilars – Oncology, women’s health